Fosun Pharma logo

Fosun Pharma

Asia, Shanghai, China, Shanghai

Description

Fosun Pharma is a pharmaceutical company.

Investor Profile

Fosun Pharma has made 9 investments, with 2 in the past 12 months and 33% as lead.

Stage Focus

  • Seed (22%)
  • Corporate Round (22%)
  • Series C (22%)
  • Debt Financing (11%)
  • Series Unknown (11%)
  • Series D (11%)

Country Focus

  • United States (44%)
  • China (33%)
  • Israel (11%)
  • United Kingdom (11%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Medical Device
  • Pharmaceutical
  • Biopharma
  • Oncology
  • Life Science
  • Genetics
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fosun Pharma frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
GE Healthcare
North America, Illinois, United States, Chicago
Co-Investments: 1
BXR Partners LLP
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Apricot Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Kite Pharma
North America, California, United States, Los Angeles
Co-Investments: 1
Docor International Management
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
Mana Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Everbright
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
Proxima Ventures Ltd
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1

What are some of recent deals done by Fosun Pharma?

Conjustar

Shanghai, Shanghai, China

Conjustar, a protein-conjugated medicine developer, has established a robust R&D pipeline through its independent and introduction efforts.

Health CareMedicalPharmaceutical
SeedJan 16, 2025
Amount Raised: $13,639,588
Fosun Kite Biotechnology

Shanghai, Shanghai, China

Fosun Kite Biotechnology develops immune cell therapy products.

BiotechnologyPharmaceutical
Corporate RoundSep 16, 2024
Amount Raised: $1,409,741
VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedSep 20, 2023
Amount Raised: $3,125,000
Gyroscope Therapeutics

Stevenage, Herefordshire, United Kingdom

Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.

BiotechnologyGeneticsHealth CareTherapeutics
Series CMar 26, 2021
Amount Raised: $148,586,567
Fosun Kite Biotechnology

Shanghai, Shanghai, China

Fosun Kite Biotechnology develops immune cell therapy products.

BiotechnologyPharmaceutical
Corporate RoundJul 9, 2020
Amount Raised: $20,000,000
Butterfly Network

Burlington, Massachusetts, United States

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

ElectronicsHealth CareMedical DevicePersonal Health
Series DSep 27, 2018
Amount Raised: $250,000,000
Ambrx

La Jolla, California, United States

Ambrx is a clinical-stage biopharmaceutical company using expanded genetic code technology for next-gen therapies and immune modulation.

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics
Series UnknownAug 4, 2016
Amount Raised: $45,000,000
Spirosure

Pleasanton, California, United States

Spirosure develops breath-analysis devices to use novel breath-based analysis in disease diagnosis and management.

Health CareMedical Device
Series CJun 30, 2016
Amount Raised: $17,400,000
Check-Cap

Isfiyeh, Hefa, Israel

Check-Cap is a young and dynamic medical device company with breakthrough solution for Colorectal Cancer Screening.

BiopharmaBiotechnologyHealth CareMedical Device
Debt FinancingOct 19, 2014
Amount Raised: $12,000,000